Beranda › Kanker Paru Non-Sel Kecil › Vermont › Burlington
Uji klinis Kanker Paru Non-Sel Kecil di Burlington, VT
4 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Burlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- University of Vermont Medical Center, Burlington
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- The University of Vermont Medical Center Inc., Burlington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- The University of Vermont Medical Center Inc., Burlington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Burlington
- Gagal Jantung8 studi
- Leukemia Mieloid Akut7 studi
- Kanker (semua jenis)6 studi
- PPOK5 studi
- Kanker Payudara5 studi
- Leukemia4 studi
- Penyakit Parkinson4 studi
- Kanker Paru4 studi
- Penyakit Kardiovaskular4 studi
- Fibrosis Kistik4 studi
- Kanker Prostat4 studi
- Kanker Metastatik4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.